Structural Biology-Inspired Discovery of Novel KRAS-PDE delta Inhibitors
Jiang, Y., Zhuang, C., Chen, L., Lu, J., Dong, G., Miao, Z., Zhang, W., Li, J., Sheng, C.(2017) J Med Chem 60: 9400-9406
- PubMed: 28929751 
- DOI: https://doi.org/10.1021/acs.jmedchem.7b01243
- Primary Citation of Related Structures:  
5X72, 5X73, 5X74 - PubMed Abstract: 
Structural biology is a powerful tool for investigating the stereospecific interactions between a protein and its ligand. Herein, an unprecedented chiral binding pattern was observed for inhibitors of KRAS-PDEδ interactions. Virtual screening and X-ray crystallography studies revealed that two enantiomers of a racemic inhibitor could bind at different sites. Fragment-based drug design was used to identify highly potent PDEδ inhibitors that can be used as promising lead compounds for target validation and antitumor drug development.
Organizational Affiliation: 
School of Pharmacy, Second Military Medical University , Shanghai 200433, China.